APA

Sachdeva J., Mahesh K. V., Shree R., Jain G., Kapila A. T., Shashikala T. P., Goyal M. K., Modi M. & Lal V. (20201127). Use of rituximab in muscle-specific tyrosine kinase antibody-positive myasthenia gravis: Preliminary observations from a tertiary care center in Northern India. : Indian journal of pharmacology.

Chicago

Sachdeva Julie, Mahesh Karthik Vinay, Shree Ritu, Jain Gaurav, Kapila Aastha Takkar, Shashikala Tirulapati Padmavathi, Goyal Manoj Kumar, Modi Manish and Lal Vivek. 20201127. Use of rituximab in muscle-specific tyrosine kinase antibody-positive myasthenia gravis: Preliminary observations from a tertiary care center in Northern India. : Indian journal of pharmacology.

Harvard

Sachdeva J., Mahesh K. V., Shree R., Jain G., Kapila A. T., Shashikala T. P., Goyal M. K., Modi M. and Lal V. (20201127). Use of rituximab in muscle-specific tyrosine kinase antibody-positive myasthenia gravis: Preliminary observations from a tertiary care center in Northern India. : Indian journal of pharmacology.

MLA

Sachdeva Julie, Mahesh Karthik Vinay, Shree Ritu, Jain Gaurav, Kapila Aastha Takkar, Shashikala Tirulapati Padmavathi, Goyal Manoj Kumar, Modi Manish and Lal Vivek. Use of rituximab in muscle-specific tyrosine kinase antibody-positive myasthenia gravis: Preliminary observations from a tertiary care center in Northern India. : Indian journal of pharmacology. 20201127.